- Home
- KPTI vs NVCT Comparison
KPTI vs NVCT Comparison
Compare KPTI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | NVCT |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 220.0M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KPTI | NVCT |
|---|---|---|
| Price | $5.57 | $7.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $14.67 | $13.50 |
| AVG Volume (30 Days) | ★ 1.2M | 54.4K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.62 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $5.55 |
| 52 Week High | $10.99 | $11.52 |
Technical Indicators
Market Signals| Indicator | KPTI | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 37.63 |
| Support Level | $3.93 | $5.77 |
| Resistance Level | $6.82 | $8.46 |
| Average True Range (ATR) | 0.83 | 0.41 |
| MACD | -0.31 | -0.13 |
| Stochastic Oscillator | 13.24 | 27.29 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.